# The 10-Year Extended Follow-up of the DACAB Trial

> **NCT07480629** · — · ENROLLING_BY_INVITATION · sponsor: **Ruijin Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Coronary Artery Disease
- CABG
- Antiplatelet Therapy of Coronary Artery Bypass

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07480629
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-03-15
- **Primary completion:** 2026-04
- **Final completion:** 2026-06
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07480629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07480629, "The 10-Year Extended Follow-up of the DACAB Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07480629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*